Published online Oct 27, 2023. doi: 10.4240/wjgs.v15.i10.2294
Peer-review started: June 12, 2023
First decision: August 10, 2023
Revised: August 17, 2023
Accepted: September 4, 2023
Article in press: September 4, 2023
Published online: October 27, 2023
Processing time: 136 Days and 20.2 Hours
Given the poor prognosis of patients with lymph node metastasis, estimating the lymph node status in patients with early esophageal cancer is crucial. Indicators that could be used to predict lymph node metastasis in early esophageal cancer have been reported in many recent studies, but no recent studies have included a review of this subject.
This study aimed to review indicators predicting lymph node metastasis in early esophageal cancer.
This study was designed to review indicators predicting lymph node metastasis in early esophageal squamous cell carcinoma (ESCC) and early esophageal adenocarcinoma (EAC).
We searched PubMed with “[early esophageal cancer (Title/Abstract) and (lymph node (Title/Abstract)]” or “[early esophageal carcinoma (Title/Abstract)] and [lymph node (Title/Abstract)]” or “[superficial esophageal cancer (Title/Abstract)] and [lymph node (Title/Abstract)].” All studies were reviewed in detail, and a total of 29 studies were eligible for analysis.
Preoperative imaging, serum microRNA-218, depth of invasion, tumor size, differentiation grade, lymphovascular invasion, neural invasion, expression of PIM-1 < 30% were predictive factors for lymph node metastasis in both early ESCC and EAC. Serum thymidine kinase 1 ≥ 3.38 pmol/L, cytokeratin 19 fragment antigen 21-1 > 3.30 ng/mL, stanniocalcin-1 and overexpression of cortactin, mixed-lineage leukaemia 2, stathmin-1 were predictive for lymph node metastasis in early ESCC. Transcription of CD69, myeloid differentiation protein 88, toll-like receptor 4 and low expression of olfactomedin 4 were predictive of lymph node metastasis in early EAC. A total of 6 comprehensive models for early ESCC were reviewed. The areas under the receiver operating characteristic curve reached 0.789-0.938.
Various factors were predictive of lymph node metastasis in early ESCC and EAC. Several comprehensive models performed well, but these models relied on postoperative pathology. Further studies focusing on serum markers, imaging and immunohistochemical indicators are still in need.
Further studies focusing on serum markers, imaging and immunohistochemical indicators are still needed.